Martínez BA, Maldonado HJ, López AM

Language: Spanish
References: 38
Page: 397-404
PDF size: 521.36 Kb.

ABSTRACT

Obesity is the main risk factor for insulin resistance (IR) in the pediatric population. IR represents a link between obesity and other metabolic complications such as type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Therefore, accurate diagnosis and early intervention may reduce the incidence of T2DM and CVD in at-risk individuals. In this study we describe the techniques used to assess insulin sensitivity in pediatric populations. We also describe in detail three diagnostic tests: the glucose clamp technique, which represents the gold standard to determine tissue insulin sensitivity and insulin secretion; HOMA and QUICKI, which are indexes obtained from fasting glucose and insulin concentrations; and ISI-Composite, obtained from an oral glucose tolerance test, which provides additional information on glucose metabolism after an oral glucose load. In conclusion, the glucose clamp technique is an invasive procedure that is difficult to use in routine clinical settings. Because the cut-off points to diagnose IR with values derived from ISI-Composite have not been established for pediatric populations, HOMA and QUICKI, despite their lack of precision, remain the most used in clinical practice.

REFERENCES

1. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol 2008;159(suppl 1):S67-S74.

2. Shamah-Levy T, Villalpando-Hernández S, Rivera-Domarco JA. Resultados de Nutrición de la ENSANUT 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2007.

3. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-810.

4. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA. Indices of insulin action, disposal and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002;25:2081-2087.

5. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010;362:485-493.

6. Schwartz B, Jacobs DR, Moran A, Steinberger J, Hong CP, Sinaiko AR. Measurement of insulin sensitivity in children. Diabetes Care 2008;31:783-788.

7. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005;26:19-39.

8. Buse JB. Type 2 diabetes mellitus. En: Larsen PR, Williams RH, eds. Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders Company; 2003.

9. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.

10. Shepherd PR, Kahn BB. Glucose transporters and insulin actionimplications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-257.

11. Trout KK, Homko C, Tkacs NC. Methods of measuring insulin sensitivity. Biol Res Nurs 2007;8:305-318.

12. Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis 2010;20:79-86.

13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.

14. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing:comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.

15. Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 2004;287:E371-E385.

16. Elahi D. In praise of the hyperglycemic clamp: a method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care 1996;19:278-286.

17. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004;144:47-55.

18. Uwaifo GI, Parikh SJ, Keil M, Elberg J, Chin J, Yanovski JA. Comparision of insulin sensitivity, clearance and secretion estimates using euglycemic and hyperglycemic clamps in children. J Clin Endocrinol Metab 2002;87:2899-2905.

19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.

20. Wallace TM, Levy JC, Mathews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.

21. Katz A, Nambi SS, Mather K, Baron A, Follmann D, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Edoncrinol Metab 2000;85:2402-2410.

22. Boyko EJ, Jensen CC. Do we know what homeostasis model assessment measures? If not, does it matter? Diabetes Care 2007;30:2725-2728.

23. Keskin M, Kurtoglu S, Kendirci M, Atabek M, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-e503.

24. Caceres M, Teran CG, Rodriguez S, Medina M. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity. BMC Pediatr 2008;8:31.

25. García-Cuartero B, García-Lacalle C, Jiménez-Lobo C, González-Vergaz A, Calvo-Rey C, Alcázar-Villa MJ, et al. Índice de HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular. An Pediatr (Barc) 2007;66:481-490.

26. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2011;34(suppl 1):S11-S61.

27. Mooy JM, Grootenhuis PA, DeVries H, Kostense PJ, Popp-Snijders C, Bouter LM, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study; Diabetologia 1996;39:298-305.

28. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008;93:4231-4237.

29. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes obtained from the oral glucose tolerance test. Diabetes Care 2007;30:89-94.

30. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-548.

31. Abdul-Ghani M, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007;30:1544-1548.

32. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671.

33. Rodbard HW. Diabetes screening, diagnosis and therapy in pediatric patients with type 2 diabetes. Medscape J Med 2008;10:184.

34. American Diabetes Association. Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 2000;23:381-389.

35. Scott LK. Insulin resistance syndrome in children. Pediatr Nurs 2006;32:119-124.

36. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Loredana MM, Chiarelli F and on behalf of ESPE-LWPESISPAD- APPES-APEG-SLEP-JSPE, and the Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metabl 2010;95:5189-5198.

37. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.

38. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-1350.